Intellectual property

Intellectual
property

Expanding our intellectual property is essential in order for us to successfully pursue our strategy and achieve our ambition.

Since 2010, LNC has secured a number of patents for its Stablor® product. Its formulation and clinical results are therefore protected, with exclusive rights applicable in 4 major pharmaceutical markets: the United States, Europe, South America and China.

We intend to build a strong IP position in the Christensenella space by filing our own IP (applications have been filed in EU and US), by licensing in available patents and patent applications from academics and by acquiring proprietary Christensenella strains.

In September 2018, we acquired an exclusive licence for the Christensenella patents from Cornell University (Ithaca, NY, USA) in order to pursue our development program.

Lastly, we are actively scouting at the international level for patent licensing opportunities, as well as new patents to acquire in order to continue expanding our intellectual property portfolio.

Microbiome & us
News
Nov 5, 2019
LNC Therapeutics Announces Formation of its Scientific Advisory Board | Appoints international experts with...
> more
Oct 22, 2019
LNC Therapeutics chooses Luina Bio for the development and GMP manufacturing of its first live bio therapeutic product...
> more
Press / Media
Nov 12, 2019
Biotechs investments disrupt Big Pharma business model The pharmaceutical industry is in a state of flux, with...
> more
Sep 6, 2019
Chaque semaine, Maddyness dresse le bilan des levées de fonds de la semaine qui vient de s’écouler. Cette semaine,...
> more
Publications
Jan 11, 2019
Comparison of the Gut Microbiota of Centenarians in Longevity Villages of South Korea with Those of Other Age Groups...
> more
Jan 2, 2019
Gut Microbes and Health: A Focus on the Mechanisms Linking Microbes, Obesity, and Related Disorders   Marialetizia...
> more
now on twitter
LNC Therapeutics

A new study indicates that poor sleep can negatively affect your gut microbiome, which can, in turn, lead to additi… t.co/ecLUwm0wLs

LNC Therapeutics © 2019 - all rights reserved terms and conditions